e-ESO Podcasts

Oncohumanities postgraduate programme: Understanding humanity disciplines to tackle challenges in cancer care 13.04.2023 7:11 ↓

Experts: Giovanni Boniolo, University of Ferrara, Ferrara, IT Fedro A. Peccatori, European Institute of Oncology, Milan, Italy

Borderline operable gastric cancer: when to go strict for surgery or peri-operative treatment? 06.04.2023 11:06 ↓

Experts: Ramon Andrade Bezerra de Mello, Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Anna Mironova, I.M. Sechenov First Moscow State Medical University, Moscow, RU

Shared decision-making in breast cancer care: from theory to practice 30.03.2023 12:02 ↓

Expert: Natalia Oprea, SDA Bocconi School of Management, Milan, Italy

Pregnancy after breast cancer 23.03.2023 12:09 ↓

Experts: Hatem A. Azim Jr., Monterrey Institute of Technology, Monterrey, Mexico Matteo Lambertini, University of Genova - San Martino Hospital, Genoa, Italy

Bone health in Prostate Cancer patients 16.03.2023 13:56 ↓

Expert: Aurelius Omlin, Onkozentrum Zurich, Zurich, CH

MonarcHER study 09.03.2023 6:29 ↓

Expert: Kristina Jankovic, University Clinical Centre Niš, Niš, Serbia

Comparison between different radiations therapy techniques for management of primary brain tumors 02.03.2023 25:52 ↓

Experts: Rasha Mohamed AbdelMotagalee Aboelhassan , Nasser Institute, Cairo, Egypt Asmaa Mohamed Taha , Nasser Institute, Cairo, Egypt

Side effects and supportive care in prostate cancer treatments: Side effects of ADt and how to mitigate them 23.02.2023 13:21 ↓

Expert: Aurelius Omlin, Onkozentrum Zurich, Zurich, CH

Managment of thymic tumors 16.02.2023 8:09 ↓

Experts: Mohamed Emam Salah Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt Hala Aziz, National Cancer Institute, Cairo, Egypt

Evaluating Pain Management Practices for Cancer Patients among Health Professionals: A Global Survey 09.02.2023 12:44 ↓

Expert: Mohamed Hablas, Gharbia Cancer Society, Tanta, Egypt

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review 02.02.2023 6:10 ↓

Expert: Andrei Kachmazov, P. A. Hertsen Moscow Oncology Research Center, Moscow, Russian Federation

Basics of prostate cancer pathology 26.01.2023 16:40 ↓

Expert: Marina Puchinskaya, Minsk City Clinical Cancer Centre, Minsk, Belarus

Oligometastaic breast cancer 19.01.2023 17:24 ↓

Expert: Maha Al Sendi, St. Vincent University Hospital, Dublin, Ireland

Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias 12.01.2023 6:10 ↓

Expert: Chiara Corti, European Institute of Oncology (IEO), Milan, IT

Summary/Review - Reporting Guidelines - CHEERS 06.12.2022 7:38 ↓

Expert: Luca Bertolaccini, Thoracic Surgeon, European Institute of Oncology, Milan, Italy

Role of immunotherapy in head and neck cancer 01.12.2022 16:15 ↓

Experts:  Mohamed Emam Salah, National Cancer Institute Cairo, Nasr City, Egypt Rasha Mohamed AbdelMotagalee Aboelhassan, Nasser Institute Hospital, Cairo, Egypt

AYAs with cancer: the right to be forgotten 24.11.2022 7:55 ↓

Expert: Giuseppe Luigi Banna, Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Summary/Review - Reporting Guidelines - SQUIRE 17.11.2022 8:20 ↓

Expert: Luca Bertolaccini, Thoracic Surgeon, European Institute of Oncology, Milan, Italy

Male breast cancer 10.11.2022 16:15 ↓

Expert: Kristina Jankovic, University Clinical Centre Niš, Niš, Serbia

Summary/Review - Reporting Guidelines - SRQR 03.11.2022 7:46 ↓

Expert: Luca Bertolaccini, Thoracic Surgeon, European Institute of Oncology, Milan, Italy

Summary/Review - Reporting Guidelines - AGREE 27.10.2022 8:38 ↓

Expert: Luca Bertolaccini, Thoracic Surgeon, European Institute of Oncology, Milan, Italy

Breast Cancer: Frequently Asked Questions and Answers 20.10.2022 15:45 ↓

Expert: Ornella Garrone, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

The role of Medical Physicist in Oncology 13.10.2022 13:13 ↓

Expert: Virginia Piva, University of Milan, Milan, Italy

How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively? 06.10.2022 17:34 ↓

Experts: Ramon Andrade Bezerra de Mello, Nine of July University (UNINOVE), Sao Paulo, Brazil Thais Vazquez,  University of São Paulo and Cancer Institute of State the São Paulo, Sao Paulo, Brazil

Parp inhibitors in ovarian cancer 29.09.2022 16:21 ↓

Expert: Katia Roque Perez, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru